An imbalance of cholesterol serum concentrations characterizes dyslipidemia. It can cause plaque formation in the arteries, increasing the chance of atherosclerotic cardiovascular illness events, such as stroke or coronary artery disease. In individuals with mixed dyslipidemia and primary hypercholesterolemia without reaction to exercise, diet, or different non-pharmacological treatments, all statins were suggested. They have shown positive outcomes in preventing cardiovascular events risk in such patients. To review the risk factors of dyslipidemia and the role of statins in treating such a disease in the recent literature. Articles were selected by the PubMed database, and these keys were utilized in the Mesh ((“Dyslipidemia” [Mesh]) AND (“Statins”[Mesh]) OR (“management” [Mesh])). Statins have been shown to lower major non-fatal atherothrombotic events and cardiovascular mortality in various groups’ primary and secondary preventive studies. Therefore, they are recommended for individuals with established heart disease, diabetes mellitus, an LDL above 190 mg/dL, and those with a 7.5% or greater 10-year risk of cardiovascular events.